

Author: Johnson Clint
Publisher: Springer Publishing Company
ISSN: 0167-6806
Source: Breast Cancer Research and Treatment, Vol.133, Iss.3, 2012-06, pp. : 889-898
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Ductal carcinoma in situ (DCIS) is a non-obligate precursor to invasive ductal carcinoma (IDC). Annotation of the genetic differences between the two lesions may assist in the identification of genes that promote the invasive phenotype. Synchronous DCIS and IDC cells were microdissected from FFPE tissue and analysed by molecular inversion probe (MIP) copy number arrays. Matched IDC and DCIS showed highly similar copy number profiles (average of 83% of the genome shared) indicating a common clonal origin although there is evidence that the DCIS continues to evolve in parallel with the co-existing IDC. Four chromosomal regions of loss (3q, 6q, 8p and 11q) and four regions of gain (5q, 16p, 19q and 20) were recurrently affected in IDC but not in DCIS. CCND1</i> and MYC</i> showed increased amplitude of gain in IDC. One region of loss (17p11.2) was specific to DCIS. IDC-specific regions include genes with previous links to breast cancer progression and potential therapeutic targets such as AXL</i>, SPHK1</i> and PLAUR</i>.
Related content




By Oh Eun Kyeong Kim Yong-Wan Kim In-Wook Liu Hai-Bo Lee Keun-Ho Chun Heung Jae Park Dong Choon Oh Eun-Jee Lee Ah Won Bae Su Mi Ahn Woong Shick
International Journal of Oncology, Vol. 41, Iss. 6, 2012-12 ,pp. :




Histopathology of Ductal Carcinoma in Situ (DCIS) of the Breast
Current Cancer Therapy Reviews, Vol. 8, Iss. 3, 2012-08 ,pp. :


By Chin-Lenn Laura Mack Lloyd Temple Walley Cherniak William Quinn Robert Ravani Pietro Lewin Adriane Quan May
Annals of Surgical Oncology, Vol. 21, Iss. 1, 2014-01 ,pp. :